Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Coronary Artery Disease
100%
Fatty Liver
66%
Diabetes
33%
Oxidative Stress
33%
Metabolic Risk Factors
33%
Hepatic Insulin Resistance
33%
High Risk
16%
Endothelial Dysfunction
16%
Cause of Death
16%
Interleukin-6
16%
Framingham
16%
Obesity
16%
Adiponectin
16%
Hypertension
16%
Steatohepatitis
16%
Cardiovascular Risk
16%
Inflammatory Cytokines
16%
Lipotoxicity
16%
Carotid Artery
16%
Most Common Cause
16%
C-reactive Protein
16%
Risk Stratification
16%
Common Pathway
16%
Dyslipidemia
16%
Resistive State
16%
Leptin
16%
Chronic Liver Disease
16%
Cardiotoxicity
16%
Cardiovascular Risk Assessment
16%
Vasodilatation
16%
Plasminogen Activator inhibitor-1 (PAI-1)
16%
Effort Measurement
16%
Effort Testing
16%
Atherogenic Dyslipidemia
16%
Liver Accumulation
16%
Liver Infiltration
16%
Classical Risk Model
16%
Subclinical Inflammation
16%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Coronary Artery Disease
100%
Fatty Liver
66%
Cardiovascular Risk
33%
Diabetes
33%
Oxidative Stress
33%
Insulin Resistance
33%
Dyslipidemia
33%
Endothelial Dysfunction
16%
Steatohepatitis
16%
C Reactive Protein
16%
Inflammatory Cytokine
16%
Fatty Acid
16%
Risk Stratification
16%
Interleukin-6
16%
Chronic Liver Disease
16%
Exercise Test
16%
Framingham Risk Score
16%
Vasodilatation
16%
Lipotoxicity
16%
Plasminogen Activator Inhibitor-1
16%
Common Hepatic Artery
16%
Carotid Artery
16%
Cardiotoxicity
16%
Adiponectin
16%
Leptin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Coronary Artery Disease
100%
Fatty Liver
66%
Cardiovascular Risk
33%
Dyslipidemia
33%
Insulin Resistance
33%
Cardiotoxicity
16%
Chronic Liver Disease
16%
Cytokine
16%
C Reactive Protein
16%
Fatty Acid
16%
Lipotoxicity
16%
Plasminogen Activator Inhibitor 1
16%
Inflammation
16%
Endothelial Dysfunction
16%
Adiponectin
16%
Leptin
16%
Framingham Risk Score
16%